Quantcast
Channel: News Medical kyphosis News Feed
Viewing all articles
Browse latest Browse all 33

Celgene to initiate apremilast Phase III placebo-controlled trial for ankylosing spondylitis

$
0
0
Celgene International Sàrl, a subsidiary of Celgene Corporation, today announced data from a Phase II study of apremilast, its investigational oral immunomodulatory compound, in patients with ankylosing spondylitis (AS) were presented at the American College of Rheumatology Scientific Meeting in Chicago, IL.

Viewing all articles
Browse latest Browse all 33

Trending Articles



<script src="https://jsc.adskeeper.com/r/s/rssing.com.1596347.js" async> </script>